Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tripartite motif-containing protein 24 (TRIM24) is a multi-domain nuclear protein belonging to the tripartite motif (TRIM) family, characterized by a RING/B-box/coiled-coil architecture, and also containing a plant homeodomain (PHD) and bromodomain that act as a combinatorial reader of specific histone modifications[1][3][4][5][6]. TRIM24 acts primarily as a chromatin-associated transcriptional coactivator, interacting with the activation function domains of several nuclear hormone receptors, including estrogen receptor (ER), androgen receptor (AR), retinoic acid, and vitamin D3 receptors[1][3][4][5]. It recruits and stabilizes transcription factors at their chromatin binding sites and modulates gene expression patterns linked to proliferation, cancer progression, and endocrine signaling[5][7]. Additionally, TRIM24 possesses E3 ubiquitin ligase activity, targeting proteins such as p53 and various innate immune pathway components for proteasomal degradation[4][6]. TRIM24 is dysregulated in multiple cancers, often acting as an oncogenic coactivator for STAT3 and nuclear receptors, and its overexpression correlates with poor prognosis, therapeutic resistance, and tumor aggressiveness[5][7]. Moreover, TRIM24 plays roles in cardiac gene expression, immune signaling, and chromatin remodeling, making it an emerging target for novel cancer therapies and a potential biomarker in oncology[2][5][7].
Proteasomal degradation of TRIM24 (by targeted protein degraders/PROTACs); Inhibition of TRIM24's coactivator functions (disrupting nuclear receptor or STAT3 interaction)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tripartite motif-containing protein 24 (TRIM24).